Res. Asst.Ceren TİLGEN YASASEVER


Onkoloji Enstitüsü, Teşhis Tedavi Ve Bakım Hizmetleri

Temel Onkoloji Ana Bilim Dalı


Research Areas: Medicine, Health Sciences, Fundamental Medical Sciences, Biochemistry, Internal Medicine Sciences, Chemistry, Biochemistry, Natural Sciences


Names in Publications: Yasasever Ceren Tilgen

Office Phone: +90 212 414 2434 Extension: 34181

Metrics

Publication

41

Citation (WoS)

131

H-Index (WoS)

7

Citation (Scopus)

150

H-Index (Scopus)

8

Project

9
UN Sustainable Development Goals

Education Information

2014 - Continues

2014 - Continues

Doctorate

Istanbul University, Onkoloji Enstitüsü, Kanser Biyokimyası Bilim Dalı, Turkey

2011 - 2014

2011 - 2014

Postgraduate

Istanbul University, Onkoloji Enstitüsü, Kanser Biyokimyası Bilim Dalı, Turkey

2008 - 2010

2008 - 2010

Postgraduate

Ankara University, Fen Fakültesi, Zooloji, Turkey

2003 - 2008

2003 - 2008

Undergraduate

Ankara University, Fen Fakültesi, Biyoloji, Turkey

Research Areas

Medicine

Health Sciences

Fundamental Medical Sciences

Biochemistry

Internal Medicine Sciences

Chemistry

Biochemistry

Natural Sciences

Academic Titles / Tasks

2014 - Continues

2014 - Continues

Research Assistant

Istanbul University, Onkoloji Enstitüsü, Temel Onkoloji Ana Bilim Dalı

Published journal articles indexed by SCI, SSCI, and AHCI

2016

2016

Clinical significance of serum caveolin-1 levels in melanoma patients

Tas F., Karabulut S., Yasasever C. T. , Duranyildiz D.

INTERNATIONAL JOURNAL OF DERMATOLOGY, vol.55, no.5, pp.558-562, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

2015

2015

Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T. , Karabulut S., Tastekin D., Duranyildiz D.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.36, no.3, pp.2097-103, 2015 (SCI-Expanded) Sustainable Development identifier identifier identifier

2014

2014

Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

Karabulut S., Aksit E., Tas F., Ciftci R., Aydiner A., Yildiz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.35, no.5, pp.4323-9, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

2012

2012

Markers of Bone Metastases in Breast and Lung Cancers

Bilgin E., Yasasever V., Soydinc H. O. , Yasasever C., Ozturk N., Duranyildiz D.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, no.9, pp.4331-4334, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

2018

2018

Tensin-2 Molekülünün Meme Kanserli Hastalardaki Önemi

YASASEVER C. T. , BILGIN E., SERİLMEZ M., OĞUZ SOYDİNÇ H., BADEMLER S., KARANLIK H., et al.

29. Ulusal Biyokimya Kongresi, Muğla, Turkey, 26 - 30 October 2018, pp.1 Sustainable Development

2017

2017

Importance of AXL Molecule in Lung Cancers

Kizir A., Bilgin Doğru E., Tilgen Yasasever C., Serilmez M.

15. İstanbul Üniversitesi Onkoloji Enstitüsü Günleri Sempozyumu ve 8. İstanbul Üniversitesi Onkoloji Enstitüsü Çalıştayı, İstanbul, Turkey, 1 - 02 December 2017, pp.1

2017

2017

Meme Kanseri Tanılı Hastalarda 25(OH)D Vitamini Düzeyleri

Hatiboğlu S., BİLGİN DOĞRU E., TİLGEN YASASEVER C., SALMAYENLİ N.

Uluslararası Katılımlı Kongre & LAB Expo 2017, Antalya, Turkey, 1 - 05 October 2017, pp.95 Sustainable Development

2017

2017

Over Kanserinde HMGB1 ve IRE1'in Önemi

BİLGİN DOĞRU E., TİLGEN YASASEVER C., SERİLMEZ M., SAİP P. M. , YASASEVER F. V.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.159 Sustainable Development

2017

2017

Clinical significance of caveolin-1 and fibronectin in pancreatic cancer

Dogru E., Yasasever C., Serilmez M., Dagoglu N., Yasasever V.

ECCO European Cancer Congress, Amsterdam, Netherlands, 27 - 30 January 2017, vol.72 Sustainable Development identifier

2017

2017

The biological role of AKT serine/threonine kinase 2 in lung cancer

Serilmez M., Karaman S., Soydinc H. O. , Yasasever C., Bilgin E., Duranyildiz D., et al.

ECCO European Cancer Congress, Amsterdam, Netherlands, 27 - 30 January 2017, vol.72 Sustainable Development identifier

2015

2015

Importance of HGMB1 serum levels in breast cancer patients

Yasasever V., Serilmez M., Yasasever C., Ciftci R.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, 4 - 09 July 2015, vol.282, pp.262 Sustainable Development identifier

2014

2014

Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development identifier

2012

2012

Leptin levels in breast cancer

Serilmez M., Soydinc H. O. , Bilgin E., Yasasever C., Duranyildiz D.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.101-102 Sustainable Development identifier

2012

2012

Significance of NSE in various cancer types

Bilgin E., Soydinc H. O. , Yasasever C. T. , Serilmez M., Yasasever V.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.101 Sustainable Development identifier

Supported Projects

2018 - Continues

2018 - Continues

Meme Kanserli Hastaların Kan ve Tükürük Örneklerinde Cullin7 Seviyesinin AraştırılmasıSustainable Development

Project Supported by Higher Education Institutions

DURANYILDIZ H. D. (Executive), TİLGEN YASASEVER C.

2017 - 2018

2017 - 2018

Meme Tümörlerinde Tensin2 Molekülü

Project Supported by Higher Education Institutions

KARANLIK H. (Executive), TİLGEN YASASEVER C., SERİLMEZ M., BİLGİN DOĞRU E., BADEMLER S., OĞUZ SOYDİNÇ H.

2017 - 2018

2017 - 2018

Akciğer Kanserlerinde AXL MolekülüSustainable Development

Project Supported by Higher Education Institutions

KİZİR A. (Executive), SERİLMEZ M., BİLGİN DOĞRU E., TİLGEN YASASEVER C., ERTÜRK K.

2017 - 2018

2017 - 2018

Baş-Boyun Kanserlerinde DCLK1 MolekülüSustainable Development

Project Supported by Higher Education Institutions

KARADENİZ A. N. (Executive), SERİLMEZ M., KARAMAN Ş., TİLGEN YASASEVER C., BİLGİN DOĞRU E.

2017 - 2018

2017 - 2018

Meme Kanserinde CPA4 Seviyesinin Belirlenmesi ve ÖnemiSustainable Development

Project Supported by Higher Education Institutions

BADEMLER S. (Executive), SERİLMEZ M., BİLGİN DOĞRU E., KARANLIK H., TİLGEN YASASEVER C.


Congress and Symposium Activities

16 September 2021 - 18 September 2021

16 September 2021 - 18 September 2021

3rd International Cancer and Ion Channels CongressSustainable Development

Audience

İstanbul-Turkey

15 February 2021 - 17 February 2021

15 February 2021 - 17 February 2021

Critical Role of Clinical Laboratories in the Covid-19 PandemicSustainable Development

Audience

Milan-Italy

19 December 2020 - 19 December 2020

19 December 2020 - 19 December 2020

18. İSTANBUL ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ GÜNLERİ

Audience

İstanbul-Turkey

18 December 2020 - 19 December 2020

18 December 2020 - 19 December 2020

16. Ulusal Onkolojik Araştırmalar Web Çalıştayı

Audience

İstanbul-Turkey

09 December 2020 - 09 December 2020

09 December 2020 - 09 December 2020

TEOD Bilim Günü

Audience

İstanbul-Turkey

01 October 2018 - 01 October 2018

01 October 2018 - 01 October 2018

TBD ULUSLARARASI BİYOKİMYA KONGRESİ 2018, 29. ULUSAL BİYOKİMYA KONGRESİ

Attendee

Muğla-Turkey

01 September 2018 - 01 September 2018

01 September 2018 - 01 September 2018

ARAŞTIRMADA VE TIBBİ UYGULAMADA KULLANILAN MOLEKÜLER LABORATUVAR TEKNİKLERİ UYGULAMALI EĞİTİM KURSU

Attendee

Ankara-Turkey

01 July 2018 - 01 July 2018

01 July 2018 - 01 July 2018

THE 43rd FEBS CONGRESS

Attendee

Praha-Czech Republic

01 October 2017 - 01 October 2017

01 October 2017 - 01 October 2017

KONGRE&LAB EXPO 2017

Attendee

Antalya-Turkey

01 April 2017 - 01 April 2017

01 April 2017 - 01 April 2017

22. ULUSAL KANSER KONGRESİSustainable Development

Attendee

Antalya-Turkey

01 January 2017 - 01 January 2017

01 January 2017 - 01 January 2017

EUROPEAN CANCER CONGRESS ECCO 2017Sustainable Development

Attendee

Amsterdam-Netherlands

01 April 2015 - 01 April 2015

01 April 2015 - 01 April 2015

21. ULUSAL KANSER KONGRESİSustainable Development

Attendee

Antalya-Turkey

01 December 2014 - 01 December 2014

01 December 2014 - 01 December 2014

Türk Tıbbi Onkoloji Kongresi

Attendee

-Turkey

01 October 2014 - 01 October 2014

01 October 2014 - 01 October 2014

Karaköy Otofaji Sempozyumu

Attendee

-Turkey

01 September 2014 - 01 September 2014

01 September 2014 - 01 September 2014

1. Moleküler Üroloji Toplantısı

Attendee

-Turkey

01 June 2014 - 01 June 2014

01 June 2014 - 01 June 2014

IFCC WorldLab İstanbul

Attendee

-Turkey

01 September 2012 - 01 September 2012

01 September 2012 - 01 September 2012

FEBS Congress

Attendee

-Spain

01 November 2011 - 01 November 2011

01 November 2011 - 01 November 2011

3. DETAE Günleri

Attendee

-Turkey

Citations

Total Citations (WOS): 131

h-index (WOS): 7